Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
European Journal of Immunology
|
September 3, 2010
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
Christopher T Harp, Sara Ireland, Laurie S Davis, et al.
Neurology
|
February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A Nash, George J Hutton, Michael K Racke, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
Xavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.
Neurology
|
December 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial
Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 30, 2022
Toward Precision Phenotyping of Multiple Sclerosis
David Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis
Roman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Journal of Crohn'S & Colitis
|
September 30, 2017
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study
Geert D'Haens, Séverine Vermeire, Harald Vogelsang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 4, 2015
Update on biomarkers in neuromyelitis optica
Esther Melamed, Michael Levy, Patrick J Waters, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
European Journal of Immunology
|
September 3, 2010
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
Christopher T Harp, Sara Ireland, Laurie S Davis, et al.
Neurology
|
February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A Nash, George J Hutton, Michael K Racke, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
Xavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.
Neurology
|
December 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial
Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 30, 2022
Toward Precision Phenotyping of Multiple Sclerosis
David Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis
Roman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Journal of Crohn'S & Colitis
|
September 30, 2017
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study
Geert D'Haens, Séverine Vermeire, Harald Vogelsang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 4, 2015
Update on biomarkers in neuromyelitis optica
Esther Melamed, Michael Levy, Patrick J Waters, et al.
Page
of 9